Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the prior Revision: v3.4.1 and a government funding lapse/operating status notice were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedGlobal site notice about a lapse in government funding and the NIH Clinical Center's status was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe update adds a glossary toggle and includes minor metadata/versioning changes (e.g., v3.4.0) along with capitalization adjustments in labeled text.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a revision update: Revision: v3.3.4 has been added and Revision: v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedLocation details are consolidated under a single 'Locations' section, replacing the previous separate state-specific sections (Arizona, Florida, Iowa, Kansas, New York, Ohio, Tennessee, Texas, Utah). The page revision is updated to v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedThe page revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.